Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update-Reference-Cited by-同舟云学术

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update

Published:2014 Issue: Volume:2014 Page:1-9
ISSN:1687-9104
Container-title:Advances in Hematology
language:en
Short-container-title:Advances in Hematology

Author:

Villafuerte-Gutierrez Paola¹,Villalon Lucia²,Losa Juan E.³,Henriquez-Camacho Cesar³

Affiliation:

1. Hospital Universitario Torrejón de Ardoz, Servicio de Hematología, Calle Mateo Inurria, 28850 Madrid, Spain

2. Hospital Universitario Fundación Alcorcón, Servicio de Hematología, Calle Budapest 1, 28922 Madrid, Spain

3. Unidad de Medicina Interna, Sección de Enfermedades Infecciosas, Hospital Universitario Fundación Alcorcón, Calle Budapest 1, 28922 Madrid, Spain

Abstract

Febrile neutropenia is one of the most serious complications in patients with haematological malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic therapy can prolong survival. This paper reviews the guidelines about febrile neutropenia in the setting of hematologic malignancies, providing an overview of the definition of fever and neutropenia, and categories of risk assessment, management of infections, and prophylaxis.

Publisher

Hindawi Limited

Subject

Hematology

Link

http://downloads.hindawi.com/journals/ah/2014/986938.pdf

Reference61 articles.

1. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

2. Febrile Neutropenia in Hematologic Malignancies

3. Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations

4. A prospective survey of febrile events in hematological malignancies

5. Management of febrile neutropenia: ESMO Clinical Practice Guidelines

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study;Cureus;2024-02-28

2. The Use of Granulocyte Colony-Stimulating Factor as Primary Prophylaxis in Patients Undergoing Chemotherapy: An Experience of Moroccan Oncologists;Cureus;2024-02-19

3. In the management of febrile neutropenia; evaluation of the factors affecting the lenght of hospital stay;Turkish Journal of Clinics and Laboratory;2023-09-30

4. Microbiological Spectrum of Neutropenic Sepsis in Cancer Patients Admitted to a Tertiary Health Care Centre;Cureus;2023-08-22

5. Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes;Cureus;2023-08-02